After years of patent protection, biosimilars for Humira are set to enter the US market in 2023. The arrival of these drugs has been widely anticipated throughout the healthcare industry.

The patent for Humira, the world’s bestselling drug, expires in Europe today – opening the door for a host of cheaper biosimilars to hit the market. Sales of AbbVie’s Humira (adalimumab ...

As you’d expect for a country famed for its archeaological sites, ancient traditions and local culture rooted in a deep history, there are numerous historical landmarks in Bahrain. First and foremost, ...

Planning a family day out and looking for brilliant things to do with kids in Bahrain? After a great venue for a kids’ party, a fab soft play spot, or a super large playground? Or seeking something ...

After hours: November 29 at 4:53 PM EST Loading Chart for BIIB ...

KUWAIT CITY, Nov 9: British Airways (BA) announced it will indefinitely suspend flights to Bahrain and Kuwait by the end of March 2025 due to ongoing issues with Rolls-Royce engines powering its ...

Saturday’s FIA WEC season finale in Bahrain was followed up with the traditional Rookie Test held on Sunday. This year’s event proved to be particularly busy. A full 71 drivers took part in the pair ...

The Bahrain International Airshow (BIAS) 2024 is set to dazzle aviation enthusiasts and industry stakeholders alike from November 13-15 at Sakhir Air Base. This edition promises an array of new ...

AbbVie also faced losses in sales for its blockbuster immunology drug Humira (adalimumab), when its US patent expired in January 2023 opening up the market to Humira biosimilars and other competitors.

Bahrain has expressed deep sympathy and solidarity with Saudi Arabia following the tragic loss of two officers and the injury of another from the Joint Forces Command of the Coalition Supporting ...